Xconomy’s Digital Events →
2nd Watch CEO Doug Schneider
Sponsored · Whitepaper
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
With data from IBM Watson Health, epidemiologists can describe treatment patterns, persistence & adherence to therapy
Sponsored · Video
A Fireside Chat with Biocom President & CEO Joe Panetta
© 2007-2020, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.